Kevin McRaith, President and CEO of Welldoc®, drives the strategic vision and commercialization of pioneering digital health solutions for cardiometabolic health. With over 25 years of leadership in life sciences—spanning biotech, pharmaceuticals, and digital health—Kevin is at the forefront of advanced AI and cutting-edge digital health technology to deliver personalized insights. Under his leadership, Welldoc is revolutionizing cardiometabolic care, including obesity management in line with GLP-1 advancements. His extensive executive tenure includes pivotal roles at Human Genome Sciences, Genentech, and Abbott, following his start at Baxter Healthcare. Kevin’s expertise and foresight position Welldoc as an innovator dedicated to making a profound impact through intelligent, accessible digital health.
Kevin McRaith
President, Chief Executive Officer
